Genzyme Wins Restrictions on Generic Arthritis Drug Price

Genzyme won a preliminary injunction in its infringement suit against Seikagaku over osteoarthritis knee pain treatment Synvisc-One, setting a minimum price at which the Japanese pharmaceutical maker can sell its lower-cost generic.
Law360